Source: Annual Congress 2005 - Burden and management of obstructive airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. R. Miller, P. F. Ole, P. Lange, J. Vestbo (Birmingham, Manchester, United Kingdom; Aarhus, Copenhagen, Denmark). Prediction of respiratory disease mortality in a population sample is improved by expressing lung function impairment as FEV₁ quotient. Eur Respir J 2005; 26: Suppl. 49, 1405

Member's Comments

No comment yet.

Related content which might interest you: Prediction of all cause mortality in a population sample is improved by using FEV1 quotient Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Relationship between FEV1 reduction and respiratory symptoms in the general population Source: Eur Respir J 2003; 21: 658-663 Year: 2003 Survival quotient: an improved method for expressing severity of lung function abnormality Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Screening the general population for lung function abnormalities: yield of respiratory symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 261s Year: 2002 Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes Source: Eur Respir J 2007; 30: 616-622 Year: 2007 Lung function impairment, COPD hospitalisations and subsequent mortality Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 The evaluation of different factors that cause FEV1 decline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002 Measuring function – lung function testing in paediatric respiratory disease Source: Annual Congress 2004 - PG5 - Objective assessments in paediatric respiratory medicine Year: 2004 Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort Source: Eur Respir J 2006; 28: Suppl. 50, 160s Year: 2006 COPD patients with exertional desaturation have a higher risk of rapid lung function decline Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011 FEV1/Height2 could be a better alternative than FEV1 in predicting all cause mortality in patients with COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Polymorphisms in surfactant proteins and FEV1 decline and development of COPD in the general population Source: Eur Respir J 2006; 28: Suppl. 50, 143s Year: 2006 Association of resting respiratory rate with lung function, heart rate, fitness and mortality Source: Eur Respir J 2006; 28: Suppl. 50, 682s Year: 2006 Lung hyperinflation is a determinant of the heart rate recovery delay in COPD patients Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Predictors of accelerated decline in lung function in adult-onset asthma Source: Eur Respir J, 51 (2) 1701785; 10.1183/13993003.01785-2017 Year: 2018